The decision how and when to invest in R&D in China is a...

The decision how and when to invest in R&D in China is a strategic choice. By investing more heavily and in more complex areas of R&D in China, an MPC can signal its commitment to the Chinese market and strengthen relationships with key opinion leaders and officials there -- thus increasing its chances of thriving in the health care market now taking shape in China.